FDA Expanding Recall of Blood Pressure Drugs

Comments (0)

Since July 2018, there have been multiple recalls for blood pressure medications, with more medications added to the recall list on an ongoing basis. The FDA recently expanded an existing recall, because of the blood pressure drug’s link to some types of cancers. 

The newest drug to be added to the recall list is 32 lots of the drug losartan, which is sold by Macleods Pharmaceuticals. The recall includes two lots of 50-milligram potassium tablets and 30 lots of potassium/hydrochlorothiazide combination tablets. 

Losartan is an angiotensin II receptor blocker, or ARB, which is used to treat hypertension and hypertensive patients who have left-ventricular hypertrophy. According to the FDA, the drugs contain unacceptable levels of certain containments, called nitrosamines. Because of that, the FDA says that there could be a risk of cancer in some patients who use the drug long-term. The FDA is continuing to work with drug manufacturers to reduce and remove the nitrosamines from the ARBs. 

The FDA recommends that if you are taking one of the recalled drugs, that you continue taking it until your doctor prescribes a different medication. The risk of harm to a patient’s health by discontinuing the drug without a replacement is higher than taking it for a short period of time until a replacement is prescribed. Fortunately, Macleods Pharmaceuticals has not received any reports of adverse events related to the recall. 

Unfortunately, drug manufacturers are often quick to get products on the market in a rush for profits without proper safety testing. If you believe you have been harmed by a prescription drug, you should speak with an attorney. Call the Houston prescription drug recall attorneys at Kennedy Hodges at 855-947-0707. We can help. Call us today to learn more or to schedule a free consultation on your case. You can also visit our LinkedIn page to learn more about the firm.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.